Your browser doesn't support javascript.
loading
A Bayesian perspective on Biogen's aducanumab trial.
Temp, Anna G M; Ly, Alexander; van Doorn, Johnny; Wagenmakers, Eric-Jan; Tang, Yi; Lutz, Michael W; Teipel, Stefan.
Afiliação
  • Temp AGM; German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
  • Ly A; Translational Neurodegeneration Section "Albrecht Kossel," Department of Neurology, University of Rostock, Rostock, Germany.
  • van Doorn J; Department of Psychological Methods, University of Amsterdam, Amsterdam, the Netherlands.
  • Wagenmakers EJ; Machine Learning Group, Centrum Wiskunde & Informatica, Amsterdam, the Netherlands.
  • Tang Y; Department of Psychological Methods, University of Amsterdam, Amsterdam, the Netherlands.
  • Lutz MW; Department of Psychological Methods, University of Amsterdam, Amsterdam, the Netherlands.
  • Teipel S; Department of Neurology, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China.
Alzheimers Dement ; 18(11): 2341-2351, 2022 11.
Article em En | MEDLINE | ID: mdl-35235700
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article